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Abstract
Background: Hepatitis B virus (HBV) infections play an important role in the development of hepatocellular
carcinoma (HCC). HBV X protein (HBx) is a multifunctional protein that can modulate various cellular processes and
plays a crucial role in the pathogenesis of HCC. HBx is known to interact with DNA helicase components of TFIIH, a
basal transcriptional factor and an integral component of DNA excision repair.
Results: In this study, the functional relevance of this association was further investigated in the context to DNA
repair. By site-directed mutagenesis HBx’s critical residues for interaction with TFIIH were identified. Similarly, TFIIH
mutants lacking ATPase domain and the conserved carboxyl-terminal domain failed to interact with HBx. Yeast and
mammalian cells expressing HBx
wt conferred hypersensitivity to UV irradiation, which is interpreted as a basic
deficiency in nucleotide excision repair. HBx
mut120 (Glu to Val) was defective in binding to TFIIH and failed to
respond to UV.
Conclusions: We conclude that HBx may act as the promoting factor by inhibiting DNA repair causing DNA
damage and accumulation of errors, thereby contributing to HCC development.
Background
H e p a t i t i sBv i r u s( H B V )i n f e c t i o ni nh u m a n si sam a j o r
health problem and is one of the principal causative
agents of liver disease. It is estimated that over 500 mil-
lion individuals are infected with HBV worldwide and 1
million deaths are annually attributed to the effects of
HBV infection [1-3]. The virus is associated with both
acute and chronic liver disease. Although the sequence
of events in the development of hepatocellular carci-
noma remains poorly defined, a significant correlation
has been made between long-term carriage of the virus
and the development of HCC [1]. Modes of HBV infec-
tion are generally from mother to infant (vertical) and
by sexual routes. The direct or indirect role of HBV in
the development of HCC appears complex. First, in the
absence of reproducible in vitro HBV propagation sys-
tem, the pathogenesis steps are poorly understood.
Second, there is a lack of evidence for HBV replication
in tumor cells that arise in HBV infected patients,
despite active replication in surrounding non-tumorous
hepatocytes. Furthermore, it has been observed that vir-
tually 100% of woodchucks chronically infected with
WHV at birth develop liver cancer and die of HCC [4].
Several mechanisms by which HBV infection could lead
to the development of HCC have been proposed. These
mechanisms include insertional mutagenesis upon inte-
gration, trans-activation of the cellular genes, activation
of signaling pathways, inactivation of tumor suppressor
proteins, synergy with environmental carcinogenesis and
host immune response.
One of the open reading frames of the HBV genome
encodes a protein termed HBx. HBx is required for viral
infection and has been implicated in virus-mediated
liver oncogenesis. The HBx protein has been detected in
liver tissue from patients with chronic HBV infection,
cirrhosis and hepatoma [5-10]. It is now generally
acknowledged that HBx supplied in trans can increase
gene expression of a wide variety of viral and cellular
promoters and enhancer elements [11,12]. Recent
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cytoplasmic and nuclear specific activities. A number of
cytoplasmic activities have been attributed to HBx
including, the activation of Ras/Raf/mitogen-activated
protein (MAP) kinase, MEKK1/Jun kinase, [13] protein
kinase C signal transduction pathways [14]. Several
putative nuclear targets of HBx have been revealed
including, ATF-2/CREB transcriptional factors [15-17],
RNA polymerase subunit RPB5 [18,19], tumor suppres-
sor protein p53 [20,21], TATA binding protein (TBP)
[22], a putative DNA repair protein UV-DDB [23,24],
TFIIH [25,26], and RNA polymerase II [19]. AP-2 and
C/EBP have also been implicated as potential targets of
HBx [27]. HBx has been shown to stimulate transcrip-
tion by RNA Polymerase II and III [28]. Further, HBx
was shown to induce either p53-mediated [29] or tumor
necrosis factor alpha (TNFa)-mediated apoptotic
destruction of liver cells [30-32].
The functional role of HBx during the HBV life cycle
was defined by transfecting a mutant HBV genome,
lacking functional HBx. In this case, a poor production
of viral proteins was observed [33]. In woodchucks an
essential functional role of HBx in vivo was revealed, by
the use of HBx mutant. HBx (-) mutant of woodchuck
failed to replicate in their natural host [34]. Although, in
woodchucks HBx was shown to be important for estab-
lishment of virus infection [34,35], the molecular
mechanism of HBx activity and its possible influence on
cell proliferation remains obscure.
We have shown that HBx interacts with the XPD/
ERCC2 and XPB/ERCC3 components of TFIIH and sti-
mulates the DNA helicase activity of TFIIH [25]. This
was further substantiated by Haviv and co-workers [28].
Further, we showed that HBx interacts with single-
stranded nucleic acids in vit r o[ 3 6 ] ,t h ei m p l i c a t i o n so f
which in DNA repair process remains to be investigated.
TFIIH is a multiprotein complex of 10 polypeptides [37].
Apart from being an important factor of basal transcrip-
tional machinery, TFIIH has been clearly shown to be an
integral component of the DNA repair pathway [38-41].
I nt h i ss t u d yw ee x p l o r et h ep h y s i o l o g i c a lr e l e v a n c eo f
HBx’sa s s o c i a t i o nw i t hT F I I Hi nt h ec o n t e x to fD N A
excision repair. Although, interaction of HBx with a
probable cellular repair protein UV-DDB was earlier
reported by Lee and co-workers [42], a functional role in
DNA repair which may result in lethal or hepatocarcino-
genic mutations is not understood. This is also primarily
due to the fact that a more defined role of UV-DDB in
vitro DNA repair reaction is not established. Abous-
sekhra and co-workers [43,44] have shown that the addi-
tion of UV-DDB during in vitro DNA repair reaction had
a very modest effect on the repair synthesis. On the other
hand TFIIH has been shown to be an essential compo-
nent of DNA repair both in vivo and in vitro [43,45,46]
Support for the role of HBx in DNA repair comes from
experiments with the S. cerevisiae and mammalian cells
expressing HBx, which displayed an increased UV hyper-
sensitivity. Because of the high degree of homology
between yeast and mammalian NER machinery, we have
chosen yeast nuclear extracts to investigate the biochem-
ical role of HBx in NER in vitro. Further, S. cerevisiae
offers an elegant genetic background to identify the path-
ways by which HBx may affect this process. In this con-
text, we used mutant yeast extracts with various genetic
mutations to investigate the role of HBx in the NER
pathways. Our results are consistent with the hypothesis
that HBx impedes the DNA repair process.
Methods
Saccharomyces cerevisiae strains and plasmids
The genotype of S. cerevisiae wild type strain 334 is
MATa pep4-3 prb1-1122 ura3-52 leu2-3, 112 regI-50
gal1. Two NER defective yeast strains rad 1 and rad51
were employed in this study. The genotype of Rad1 is (a
rad1-2 his3Δ1 leu2-3-112 lys 1-1 trp1-289 ura3-52) and
rad 51 (a rad51-1 his3Δ1 leu2-3-112 lys 1-1 trp1-289
ura3-52). Plasmids pUC18 and pBR322 were used for
repair synthesis assays and were purified as described
[47]. Plasmid pSBDR contains sequences encoded by an
HP1 to Taq1 fragment derived from HBV adw strain
which includes enhancer 1 element followed by X pro-
moter, the HBx coding sequences and the polyA addition
site. In addition, pSBDR contains neomycin resistance
marker for selection in eukaryotic cells.
UV survival profile of HBx expressing yeast cells
Yeast cultures of strain 334 containing plasmids, pYES
and pYES-X
wt and pYES-X
mutant (as indicated) were
grown in 2 ml of YMIN media (0.17% yeast nitrogen
base, 1% succinic acid, 0.6% NaOH and 0.5% Ammo-
nium sulfate) with 2% glucose. Saturated yeast cultures
were washed in water and resuspended into 2 ml of
sterile water. Then 200 μl of washed cells were added
into 2 ml of fresh YMIN media containing 2% glycerol,
2% ethanol and 2% galactose for the induction of HBx
and grown with shaking (200 rpm) for 24 h. Various cell
dilutions were plated simultaneously onto two sets of
YMIN plates containing 2% glycerol, 2% ethanol and 2%
galactose. One set of plates was immediately irradiated
under a germicidal lamp for various dosages of UV light
and another set of control plates was not exposed to
UV-irradiation. Plates were then incubated in dark for
at least 24 h and shifted to 30°C. Colonies were counted
to determine the survival fraction.
UV survival profile of HBx expressing human liver cells
HBx expression plasmid pSBDR and UV-damaged pRC/
CMV were co transfected into Chang liver cells. Plates
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0.4 mg/ml of G-418. The number of G-418 resistant
clones per 10
5 cells is plotted. Live cells were counted
by staining with trypan blue after transfection and prior
to G-418 selection.
Yeast nuclear extracts
Yeast cells were grown at 30°C in 1 liter YPD medium (1%
yeast extracts, 2% Bactopeptone, 2% Dextrose) to logarith-
mic phase. Cells were harvested by centrifugation for 10
min, washed in water, and suspended at 0.1 g/ml in 0.1 M
EDTA pH 8.0/10 mM dithiothreitol. After incubation at
30°C with shaking (50 rpm) for 10 min, cells were pelleted
by centrifugation as described above and suspended at 1
ml in YPS solution (1% yeast extract, 2% Bactopepetone
and 1 M sorbitol) and yeast lytic enzyme (ICN) was added
at 150 U/g of cells. Following incubation at 30°C with
shaking (50 rpm) for 2 hrs, ice cold YPS solution was
added (10 mg/g of cells). Spheroblasts were pelleted by
centrifugation as above and washed three times in the
same buffer. Phenylmethanesulfonyl flouride was added
(0.5 mM) before the final centrifugation. Cells were
washed again in 1M sorbitol and suspended at 0.125 g/ml
in 5 mM Tris-HCl, (pH7.4) 20 mM KCl, 2 mM EDTA-
KOH, (pH 7.4), 0.125 mM sperimidine, 0.05 M sperimine,
18% Ficoll, 1% thiodiglycol and with protease inhibitors.
Spheroplasts were lysed in a motor-driven homogenizer
with 10 strokes. The lysates were centrifuged in a sorvall
SW34 rotor at 10000 rpm for 10 min and then for 5 min
at 4°C. The nuclei were harvested by centrifugation at
13000 rpm for 30 min at 4°C. Nuclei were resuspended
(0.6 ml/g of nuclei) in 100 mM Tris acetate (pH 7.9), 50
mM Potassium Acetate, 10 mM MgSO4,2m ME D T A ,3
mM DTT, 20% glycerol and protease inhibitors. Then, a
solution of 4M NH4SO4 neutralized with NaOH was
slowly added to 0.9 M, gently stirred and centrifuged in a
sorvall SW34 rotor at 12000 rpm for 1 h at 4°C. The
supernatant was adjusted to 75% saturation with solid
NH4SO4 and neutralized with NaOH. Precipitates were
collected by centrifugation in a sorvall SW34 rotor at
12000 rpm for 15 min at 4°C, resuspended in 1/15th
volume of high-speed supernatant in 20 mM Hepes-KOH
(pH 7.6), 10 mM MgSO4, 5 mM DTT, 10 mM EGTA,
20% glycerol (v/v) and protease inhibitors and dialyzed
against the same buffer. Precipitates formed during dialysis
were removed by centrifugation and the resulting nuclear
extracts were stored at -70°C.
In vitro DNA repair reaction
The repair reaction contained, 0.3 μgo fu n i r r a d i a t e d
pUC18 and 0.3 μg of UV irradiated pBR322 substrate,
45 mM HEPES-KOH (pH 7.8), 70 mM KCl, 7.4 mM
MgCl2, 0.9 mM DTT, 0.4 mM EDTA, 2 mM ATP, 20
mM each of dGTP, dCTP, and dTTP, and 8 μMd A T P ,
2 μCi [a-32]dATP (3000 Ci/mmol), 40 mM phospho-
creatine, 2.5 mg creatine phosphokinase (type 1), 3.4%
glycerol, 18 mg bovine serum albumin and 100 μgo f
cell extracts. Reactions were incubated for 6 h at 30°C.
Reactions were stopped by the addition of EDTA and
then incubated with RNAse,S D Sa n dp r o t e i n a s eK .
Plasmids were digested with HindIII and loaded on 1%
agarose gel. After overnight electrophoresis, the gel was
photographed under near-UV transillumination with
Polaroid film and an autoradiograph of the dried gel
was obtained.
Synthesis and purification of an oligonucleotide
containing a single 1.3-intrastrand d(GpTpG)-Cisplatin
cross-link
Purified 24-mer oligonucleotide containing a unique
GTG sequence (5’-TCT TCT TCT GTG CAC TCT
TCT TCT-3’) was allowed to react at a concentration of
1 mM with a 3-fold molar excess of Cisplatin (3 mM)
f o r1 6ha t3 7 ° Ci nab u f f e rc o n t a i n i n g3m MN a C l ,0 . 5
mM Na2HPO4 and 0.5 mM NaH2PO4 [48]. The purifi-
cation of the platinated oligo was done by using 20%
preparative denaturing polyacrylamide gel. The oligonu-
cleotides were visualized using a hand-held UV lamp
(254 nm) after placing the appropriate region of the gel
onto TLC plate. The desired platinated oligonucleotide
was excised, crushed and suspended in 1 ml H2O. The
suspension was incubated overnight with agitation. The
supernatant containing the platinated oligo was lyophi-
lized and purified using Sephadex G25 column.
Synthesis and purification of covalently closed circular
DNA (cccDNA)
Covalently closed circular DNA containing a single 1,3-
intrastrand d(GpTpG)-Cisplatin cross link (pt-GTG) was
produced by priming 30 μg of plus strand M13 mp18
DNA modified to contain a sequence complementary to
the platinated oligonucleotide within the polycloning
site [48] with a 5-molar excess of 5’-phosphorylated pla-
tinated oligonucleotide in a 200-μl reaction mixture
containing 10 mM Tris-HCl (pH7.9), 50 mM NaCl, 10
mM MgCl2, 1 mM DTT, 600 μMe a c ho fd A T P ,d C T P ,
dGTP and TTP, 2 mM ATP, 60 units of T4 DNA poly-
merase and T4 ligase (New England Biolab) for 4 h at
37°C. Closed circular DNA was isolated by CsCl/EtBr
density gradient centrifugation and purified by consecu-
tive butanol extraction, centrifugation in cetricon-10
microconcentrator (Amicon) and a Sephadex G-25 col-
umn (Sigma). DNA substrates were stored at 80°C in 10
mM Tris-HCl, 1 mM EDTA pH 8.0.
Dual incision assay
Ten μl reaction mixture contain 19 μg cell extract, 32
ng pt-DNA, 5 mM MgCl2, 40 mM HEPES-KOH pH 7.8,
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tine, 18 μg bovine serum albumin (BRL, nuclease free).
The reaction mixtures were incubated for a further 30
min. To analyze the release of DNA containing the lesion,
a 34-mer oligonucleotide is used [49] as a template by
sequanase to incorporate radiolabeled dCTP on the 3’ end
of the excised fragment then the excised labelled frag-
ments were analyzed on 14% polyacrylamide gel.
Results
HBx expression modulates the UV survival profile of
Chang liver cells
The effect of HBx expression on repair efficiency of a
UV-damaged DNA in the human liver cell was moni-
tored. HBx expressing plasmid pSBDR and a neomycin
resistant plasmid pRC/CMV (control) were co-trans-
fected into Chang liver cells. In the plasmid pSBDR, the
HBx coding sequences are placed under the transcrip-
tional control of native promoter and enhancer. pRC/
C M VD N Aw a sU Vd a m a g e df o r2 ,6 ,a n d8a n d1 0J /
m
2 of UV radiation. As a control, UV-damaged pRC/
CMV DNA was co-transfected along with a plasmid
pHEN100 lacking the coding sequences of HBx. Cells
were counted prior to co-transfection and selected in
media containing G-418 for 2 weeks. Thereafter, G-418
resistant clones were counted. A decrease in the number
of G-418 resistant clones per 10
5 cells was observed in
HBx expressing cells when compared with non-expres-
sing cells (Figure 1).
HBx mutants fail to interact with TFIIH
We previously reported interactions between HBx and
two components of TFIIH, ERRC2 and ERCC3 [28]. We
identified a domain spanning aa 110-143, sufficient for
these interactions between HBx and ERCC2 and ERCC3
[25] is domain was shown to be sufficient to stimulate
the DNA helicase activity of purified TFIIH [25]. To
identify the critical amino acids required for TFIIH
interactions and associated functions, the conserved
negatively charged residues in this domain were selected
for mutagenesis studies. Using site-directed mutagenesis
technique, individual amino acid residues, Asp 113, Asp
118, Glu 120, Glu 121, Glu 124 and Glu 125 were chan-
ged to non-polar Val. These HBx mutants were
employed for interaction between HBx and ERCC2 and
ERCC3. ERCC2 protein was expressed in E. Coli as a
Maltose-ERCC2 fusion protein. Bacterial cellular
extracts were immobilized on amylose resin. In this
experiment the wild type HBx was in vitro translated
and allowed to interact with either Mal-ERCC2 resin or
with amylose beads alone. While HBx interacted with
ERCC2 (Figure 2A, lane 1), no interaction was seen with
amylose resin alone (Figure 2A, lane 6). In vitro trans-
lated
35S[methionine]-labeled HBx mutants Glu 120,
Glu 121, Glu 124, and Glu 125 proteins were allowed to
interact with Mal-ERCC2 (Figure 2A, lanes 2-5). The
r e s u l t so ft h i sa n a l y s i ss h o wt h a tH B xm u t a n tG l u1 2 0
a n dG l u1 2 1d i dn o ti n t e r a c tw i t hM a l - E R C C 2a ta n y
significant level (lanes 2 and 3). HBx mutants Glu 124
( l a n e4 )a n dG l u1 2 5( l a n e5 )s h o w e do n l yam o d e s t
reduction in binding to ERCC2 (see densitometric analy-
sis in the right panel of Figure 2A).
To map the critical residue required for the interac-
tion of HBx with ERCC3, GST pull down assay was per-
formed in which ERCC3 proteins were synthesized in
vitro in the presence of
35S[methionine] and allowed to
interact with GST-fusion protein of HBx (Figure 2B).
While wild type HBx interacted with ERCC3 (lane 2),
no interactions were seen with GST (lane 1). HBx’s
mutants Asp 113 (lane 3) and Asp 118 (lane 4) showed
normal interaction with ERCC3. On the other had
HBx’s mutant Glu 120, Glu 121 showed a reduction in
binding to ERCC3 (lane 5 and 6). No interaction has
been seen with the double mutant Glu 120/121 (lane 7).
Collectively, these studies are consistent in identifying
the Glu 120 and Glu 121 of HBx as critical residues
involved in interactions with both DNA helicase compo-
nents of TFIIH. These HBx mutant constructs provide a
stronger evidence for the specificity of our previous
resorts for the protein-protein interactions.
HBx mutants fail to interact with TFIIH
The HBx mutants were tested for their ability to physi-
cally interact with the DNA helicase components of
yeast TFIIH (yTFIIH). The RAD3 and SSL2 represent
the homologues of ERCC2 and ERCC3 components of
mammalian TFIIH. In the first experiment,
35S-[methio-
nine]-labelled wild type RAD3 component of yTFIIH
was allowed to interact with glutathione affinity beads
immobilized with either glutathione S-transferase (GST)
or GST-HBx
wt or GST-HBx
mut fusion proteins which
were extracted from bacteria (Figure 3A). After exten-
sive washing, the bound proteins were analyzed by SDS-
PAGE. In this analysis only HBx mutant Glu 120 failed
to interact with RAD3 (Figure 3A, lane 6). Other
mutants either interacted modestly or functioned as
wild type HBx (Figure 3A).
Next, we also employed
35S[methionine]-labelled SSL2
homology of ERCC3 for its ability to interact with GST-
X mutant proteins immobilized on GST affinity beads
(Figure 3B). Consistent withF i g u r e3 A ,t h er e s u l t so f
these interaction studies identified Glu 120 as a critical
residue for interaction with both components of yTFIIH.
HBx expressing yeast cells modulates the UV survival
profile
To further correlate the effect of HBx associations with
TFIIH, we employed a UV hypersensitivity assay as
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have generated a SSL2 mutant (Ssl2-xp) that mimics the
ERCC3 defect found in XP patients. This non-lethal
mutant allele of SSL2 was shown to increases the sensi-
tivity of yeast to UV irradiation when tested in an in
vivo assay for viability. Upon UV irradiation of yeast, in
which Ssl2-xp was the sole copy, 10
3 more cells died
when compared to wild type, suggesting a direct correla-
tion between defects in DNA repair enzymes and UV
hypersensitivity. Using this assay system, the influence
of HBx on DNA repair process in yeast was examined.
HBx
wt and selected HBx
mutants were cloned in the yeast
plasmid pYES with a selectable marker (Ura3) in which
X is under the control of inducible galactose promoter.
Yeast strain that lacks the galactose repressor (GAL-80)
was used to transform and subjected to UV irradiation
assay as described [50]. The results of UV irradiation
experiment shown in Figure 4A, clearly suggest that
yeast expressing HBx displayed an increased UV hyper-
sensitivity. Since, we earlier showed that HBx interacts
w i t hS S L 2a n dR A D 3c o m p o n e n to fT F I I H[ 2 5 ] ,i ti s
conceivable that the interactions between HBx and SSL2
and/or RAD3 are reflected in the impediment of cellular
DNA repair process. To address this issue, HBx point
mutants were employed. HBx mutants Glu 120, 121,
124, and 125 were transformed into yeast and assayed
for UV hypersensitivity assay. HBx
mut120 which fails to
interact with human and yeast TFIIH failed to influence
the DNA repair in yeast (Figure 4A). The expression of
HBx
mut proteins in yeast cells was confirmed by Immu-
noblotting. In all cases, similar levels of HBx expression
were observed (data not shown). The results of the UV
hypersensitivity assay are consistent with the hypothesis
that the inability of the HBx to interact with TFIIH
directly correlates with its inability to impede the DNA
repair process.
We next asked the question, does the expression of
HBx in the mutant yeast strain lacking the carboxyl-ter-
minus of SSL2 (ERCC3 homologue) affect the UV survi-
val profile? A mutant yeast strain with a deletion of
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Figure 3 Reduced interaction of HBX mutants with RAD3 (ERCC2 homolog) and SSL2 (ERCC3 homolog) components of yeast TFIIH. (A)
RAD3 was in vitro translated in the presence of
35S methionine and allowed to interact with GST (lane 1) or GST-X (lane 2), GST-XAsp113 (lane
3), GST-X Asp 118, (lane 4) GST-XGlu120 (lane 5), GST-X Glu121 (lane 6), GST-X Glu 124 (lane 7), GST-XGlu 125 (lane 8) and GST-X Glu 120/21
(lane 9).(B) SSL2 was synthesized in vitro and labeled with
35S methionine and allowed to interact with GST (lane 1) or GST-X (lane 2), GST-
XAsp113 (lane 3), GST-X Asp 118, (lane 4) GST-XGlu120 (lane 5), GST-X Glu121 (lane 6), GST-X Glu 124 (lane 7), GST-XGlu 125 (lane 8), and GST-X
Glu 120/21 (lane 9).
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Figure 4 HBx expression increases the UV sensitivity of yeast cells. (A) UV survival profile of HBx expressing yeast cells. Saturated yeast
cultures of strain 334 containing plasmids, pYES and pYES-X
wt and pYES-X
muts (as indicated), were diluted in water and plated on YMIN plates
containing 2% glucose, 2% glycerol, 2% ethanol and 2% galactose (for induction of HBx). Cells were immediately irradiated under a germicidal
lamp. Plates were then incubated in dark for at least 24 hrs and shifted to 30°C. Colonies were counted to determine the survival fraction. This is
the average of three experiments. The ordinate represents the survival fraction, while the abscissa displays the dosage of UV irradiation. (B) UV
survival profile of HBx expression in TFIIH mutant yeast cells. This is the average of three experiments. The ordinate represents the survival
fraction, while the abscissa displays the dosage of UV irradiation.
Qadri et al. BMC Microbiology 2011, 11:48
http://www.biomedcentral.com/1471-2180/11/48
Page 8 of 1579aa in the carboxyl terminus of was used in the UV-
hypersensitivity experiment [50]. The deletion in ssl2
strain overlaps with the ERCC3 deletion mutant that
contains the ATPase activity and does not interact with
HBx (data not shown). The yeast strain was transformed
with plasmid pGal4-X
wt. In the UV hypersensitivity
experiment, HBx did not affect the survival profile of
the mutant yeast strain with C-terminal deletion of
SSL2 (Figure 4b). These results suggest that TFIIH regu-
lated pathway is utilized by HBx in the impediment of
the DNA repair process and that HBx-TFIIH physical
interaction is crucial to influence this process.
Effect of HBx expression on in vitro DNA repair reaction
Next, we assayed the efficiency of HBx expressing yeast
cell lysates to repair UV-damaged plasmid DNA. This was
compared with non-expressing and HBx mutant expres-
sing cell lysates. Wang and co-workers [47] developed a
fairly simple and effective assay to monitor DNA repair in
vitro. This assay relies on the repair synthesis of a plasmid
which has been previously treated with a base-damaging
agent N-acetoxy-2-acetylaminofluorene (AAAF) or UV
irradiation. Damaged plasmids are incubated with wild
type yeast cell-free extracts and
32P-labeled dCTP. Radio-
activity incorporated into the damaged plasmid during
DNA repair is observed by agarose gel electrophoresis fol-
lowed by autoradiography. By employing the mutant
alleles of RAD3 and SSL2, Wang and co-workers [47]
were able to define a functional role for yeast TFIIH in
DNA repair. We employed this assay to determine the
effect of HBx on DNA repair process in vitro. To control
the specificity of in vitro DNA repair reaction, we also
used TFIIH (ssl2) mutant and NER defective rad 1 and
rad51 deletion yeast strains as controls.
First, UV irradiated plasmid pBR322 was subjected to
DNA repair in vitro, with extracts of wild type yeast
strain 334 and those transformed with pYES-2 (vector
alone), pYES-X (HBx expressing vector) and its mutants
Glu 120, Glu 121, Glu 124 and Glu 125. Un-irradiated
plasmid pUC18 DNA was used as a control. Yeast
lysates were prepared 16 hr after treatment with 2%
galactose for the expression of HBx and its mutant pro-
teins. HBx and its mutant proteins were expressed
equally in these yeast strains as confirmed by Western
blotting (data not shown).
F i g u r e5 As h o w st h er e s u l t so ft h i se x p e r i m e n t .T h e
repair synthesis of UV irradiated plasmid pUC18 using
the yeast crude extracts transformed with vector alone
(lane 1), HBx expressing vector, (lane 2) and HBx
mutants Glu 120 (lane 3), Glu 121 (lane 4), Glu 124 (lane
5) and Glu 125 (lane 6). The incorporation of
32P[dCTP]
as a measure of DNA repair is shown in Figure 5. These
results clearly suggest that HBx expressing yeast lysates
are defective in repairing the UV-damaged DNA in vitro
(compare lane 1 with lane 2). HBx mutant Asp 113 that
has retained the ability to interact with TFIIH (Figure
2A-C) also retains the ability to impede the DNA repair
process like wild type HBx (lane 3). Yeast lysates expres-
sing other mutants of HBx showed varying degrees of
DNA repair efficiencies (lanes 4-7). More importantly,
HBx’s mutant Glu 120 which failed to interact with
TFIIH also failed to influence the repair process in vitro
(lane 3). The results shown in Figure 5A are encouraging,
as no incorporation in the un-damaged pBR322 DNA
was observed. To further confirm that non-specific incor-
poration of radioactivity has not occurred in this reac-
tion, we used HBx expressing NER defective yeast lysates.
Two mutant yeast strains with deletions in Rad-1 and
Rad-51 were transformed with HBx expressing plasmid
pGAL4-X and a control plasmid pGAL4. Yeast lysates
were prepared after 16 hrs induction with 2% glacotose
and subjected in repair reaction (Figure 5B, lanes 3-6).
Both Rad-1 and Rad-51 NER defective lysates showed no
incorporation (lanes 3 and 5). HBx expression in these
mutant yeast lysates had no effect on the repair reaction
( l a n e4a n d6 ) .T h i ss u g g e s t st h a ti n d e e ds p e c i f i cD N A
repair reaction has occurred in Figure 5A. These results
are consistent with the hypothesis that HBx expressing
wild type yeast lysates have diminished DNA repair effi-
ciency of UV-damaged plasmid DNA.
Next, we examined the ability of HBx to alter DNA
excision repair reaction in a TFIIH mutant yeast strain
( F i g u r e5 C ) .W i l dt y p ey e a s ts t r a i na n dt w oT F I I H
mutant yeast strains ssl2 (dead) and ssl2 (ts) [37] were
transformed with a control plasmid pGAL4 and HBx
expressing pGAL4-X DNAs. Yeast lysates were prepared
as described. UV-damaged pBR322 DNA was used. Con-
sistent with our previous results, HBx expression in wild
type strain diminished the ability to repair the DNA (lane
2). TFIIH mutant yeast lysates with HBx (lane 4 and 6)
or without HBx (lanes 3 and 5) were equally deficient in
DNA repair synthesis, suggesting that HBx impinge its
influence on DNA repair via TFIIH. In summary, using
myriad experimental strategies, our results implicate HBx
in DNA repair process via its physical interactions with
the helicase components of TFIIH.
HBx protein inhibits excision of damaged DNA in the
dual incision assay
To measure the effect of X protein on the excision of
the Damaged DNA, we used 40 μg of HeLa whole cell
extract and 20 ng of Pt-DNA. Figure 6 shows that HBx
or HBx 113 mutant but not HBx120 or HBx121 is able
to inhibit the excision of the platinated fragment.
Discussion
HBx protein has been proposed to play a role in the
development of HCC. HBx has been shown to possess
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Figure 5 HBx impedes the DNA repair of UV damaged plasmid DNA in-vitro. (A) In vitro repair of UV-damaged pBR322 DNA using yeast
lysates expressing HBx and its mutants. The repair reaction contained, 0.3 μg un-irradiated pUC18 and 0.3 μg UV-irradiated pBR322 substrate,
was performed as discussed in the experimental procedure. Control plasmid (lane 1); HBx expressing plasmid (lane 2); and its mutant Glu120
(lane 3); Glu 121 (lane 4); Glu 124 (lane 5) and Glu 125 (lane6). Reactions were incubated for 6 hours at 30°C. Reactions were stopped by the
addition of EDTA and then incubated with RNAse, SDS and proteinase K. Plasmids were digested with HindIII and loaded on 1% agarose gel.
After overnight electrophoresis, the gel was photographed under near-UV transillumination with Polaroid film (right panel) and an
autoradiograph of the dried gel was obtained (left panel) (B) HBx is unable to repair the damaged plasmid DNA in Rad1 and Rad51 mutant
yeast strain. Plasmid p-GAL4 and pGAL4-X were transformed into yeast strains with normal RAD1 and RAD51 genes (lane 1, 2), with deletion of
Rad1 (lane 3, 4) and with deletion of RAd51 (lane 5-6). Nuclear extract were assayed for DNA repair of UV-damaged pUC18 DNA (C) HBx is
unable to repair damaged plasmid DNA in SSL2 mutant (dead) and temperature sensitive yeast strain. Plasmid p-Gal4 and pGAL4-X were
transformed into yeast strains with normal SSL2 (lane 1, 2) mutant SSL2-dead strain (lane 3, 4) and temperature strain (lane 5-6). Nuclear extracts
were assayed for DNA repair of UV-damaged pBR322 DNA The yeast ts strain was grown at room temperature (20-21°C).
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Page 10 of 15pleiotropic functions including impairment of cell cycle
progression [51], interaction with transcription machin-
ery [9-13], and cell signal transduction and apoptosis
mechanisms [29,52-54]. Furthermore, HBx associated
physically with p53 resulting in the sequestration of p53
in the cytoplasm (28), inhibition of p53 function includ-
ing its DNA binding and transactivation activities [55]
as well as p53 interaction with XPB protein [55]. Several
studies suggested a potential role of HBx cellular DNA
repair process. This is borne out by its associations with
TFIIH [25,28], a probable DNA repair factor UV-DDB
[23,42,56], p53 tumor suppressor protein [55,57], ss-
DNA [36], and UV-damaged DNA [58,59].
HBx expression inhibit DNA repair
Our study provides evidence that HBx can inhibit DNA
repair pathway. In the absence of UV damage, cells
expressing HBx were found to be similar to control cells
in cell growth measured by colony formation assay
(Figure 1). Similar observations were reported by Lee
and co-workers [60]. They demonstrated that HBx
expression did not affect the morphology, viability, and
cell cycle/apoptosis profiles or DNA repair machinery of
UV-untreated HepG2 cells. However, HBx-expressing
cells exhibited increased sensitivity to UV damage and
reduced DNA repair capacity. It has been shown that
mice carrying HBx as a transgene show a direct correla-
tion between the level of HBx expression and the likeli-
hood to develop HCC [61,62]. However certain lineages
of HBx transgenic mice do not exhibit tumour develop-
ment unless coupled with other factors such as exposure
to the hepatocarcinogen diethylnitrosamine [63] or
when combined with c-myc induction [64]. It has been
suggested previously that HBx does not directly cause
cancer but plays a role in liver oncogenesis as a cofactor
or tumour promoter [60]. Chronic HBV infection may
present a long-term opportunity for an initiating event
to occur, and HBx may act by modifying cellular regula-
tory/control mechanisms facilitating the culmination of
the transformation process in the cell. In this regard, a
highly probable tumour-initiating event is DNA damage.
HBx mutants failed to interact with TFIIH
We continue to characterize the specific domains of
HBx involved in affecting the DNA repair process. We
have employed approaches to elucidate the mechanism
(s) by which HBx interactions with DNA excision
repairs factor TFIIH could lead to impaired DNA repair.
DNA repair system is the primary defence against accu-
mulation of mutations in genomic DNA and activation
of cellular carcinogenesis. Deficiencies in DNA repair
pathways have been linked to common cancer predispo-
sition syndromes. Notable among these are the heredi-
tary nonpolyposis colorectal cancer (HNPCC) and skin
cancer or xeroderma pigmentosum [46,65]. DNA repair
occurs by kinetically two different pathways: one
involved with repair of the overall genome (global
repair) and one involved with repair of transcribed
genes (transcription coupled-repair) [46,66,67]. Studies
have demonstrated that some of the essential DNA
repair proteins in yeast and mammalian cells are a part
of basal transcription factor TFIIH [26,67,68]. In
humans, the defects in XPD/ERCC2 and XPB/ERCC3
genes lead to xeroderma pigmentosum (XP) [69] and
Cockayne’s Syndrome (CS) [65,66]. Both conditions are
manifested by the inability of the cells to efficiently
repair damaged DNA. In yeast, RAD3 and SSL2
(RAD25) are the homologues of XPD/ERCC2 and XPB/
ERCC3 respectively. These genes are essential both in
yeast and mammals.
Since TFIIH is one of the minimal set of factors
required for transcription initiation and DNA excision
repair, the association of HBx implicates a fundamental
role in the processes affected by HBx [70,71]. A large
body of data, supports the transcriptional transactivation
role of HBx [11,72,73]. It remains to be determined if
HBx’s ability to stimulate DNA helicase activity of
ERCC2/ERCC3 [25] is functionally relevant to both
DNA repair and transcription initiation.
Mapping of the functional domain of HBx
Many studies showed that HBx plays an important role
in HCC pathogenesis by interacting with cellular onco-
genes [21-23] and that its functional domain involved in
oncogenesis is at the middle of HBx protein [24,25].
Several studies have also shown that HBx can induce
apoptosis [26-29].
Tang and co-worker has mapped the coactivation
domain within the C-terminal, two thirds of which
Dual incision products
1        2        3        4        5 
Figure 6 HBx protein inhibits excision of damaged DNA in
dual incision assay. Measurement of the effect of X protein on the
dual excision of the Damaged DNA using 40 μg of HeLa whole cell
extract and 20 ng of Pt-DNA. GST (lane 1) or GST-X (lane 2), GST-
XAsp113 (lane 3), GST-XGlu120 (lane 4), GST-X Glu121 (lane 5).
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Page 11 of 15(aa51-138) is identified to that of the transactivation. In
contrast, the N-terminal of HBx has the ability to down
regulate transactivation and was defined as the negative
regulatory domain [74].
It has been shown recently that the COOH-terminal
truncated HBx plays a critical role in the HCC carcino-
genesis via the activation of cell proliferation [75].
Alteration of HBV X gene has been detected more fre-
quently in tissue samples of cirrhosis and/or HCC than
in those of mild liver disease [76]. However, the
mechanism of HBx in HCC carcinogenesis is still
unclear, although many studies have associated it to
ability of HBx trans-activating cellular oncogenes and
signaling cascades that stimulate cell proliferation and
lead to HCC carcinogenesis [1,17,77-79]. It has been
demonstrated that the full-length HBx contains two
function domains: oncogenic domain (the NH2 terminal
through middle peptide) and proapoptotic domain (the
COOH-terminal peptide). T h e r ei sab a l a n c eb e t w e e n
these two functions in HBV-infected hepatocytes. When
the proapoptotic domain is deleted by an unknown
mechanism during the viral integration, the balance is
broken and the oncogenic function becomes dominant,
leading to the subsequent development of HCC.
HBx has been shown to enhance cell susceptibility to
cytotoxic effect of genotoxic agents, e.g. UVC and afla-
toxins, that induce bulky adducts. This effect has been
linked to impaired regulation of DNA repair and asso-
ciated cell cycle checkpoint mechanisms [24-27], and/or
the proapoptotic effect of HBx [45]. DNA damage
induced by bulky adducts are preferred substrates for
NER mechanism, where the TFIIH repair complex plays
an essential role [30]. Inhibition of TFIIH activity by
HBx may inhibit DNA repair and hence promote cells
to undergo apoptosis. While several studies have
focused on the transactivation capacity of the HBx pro-
tein in carcinogenesis, our data indicates that HBX is
capable of transcriptional repression while maintaining
it transactivation functions on NF-kB and AP1 respon-
sive elements. The implication of transactivation in car-
cinogenesis is demonstrated primarily in transient
systems and there is evidence that HBx-induced transac-
tivation is not sufficient for cell transformation [47]. The
observation that HBx suppresses XPB and XPD in liver
tissue from HBx-transgenic mice supports the biological
relevance of our findings. XPB and XPD helicase and
ATPase activities, but not the TFIIH kinase, are required
for NER function [30-33].
Previous studies have shown that HBx inactivate the p53
tumour suppressor protein and impair DNA repair, cell
cycle, and apoptosis mechanisms. HBx was shown to
represses two components of the transcription-repair fac-
tor TFIIH, XPB (p89), and XPD (p80), both in p53-profi-
cient and p53-deficient liver cells. This inhibition is
observed while HBx maintains its transactivation function.
Expression of HBx in liver cells results in down-regulation
of endogenous XPB and XPD mRNAs and proteins. In
liver tissue from HBx transgenic, XPB and XPD proteins
are down-regulated in comparison to matched normal
liver tissue [48]. HBx expression on hepatocytes nucleotide
excision repair has been successfully studied in primary
wild-type and p53-null mouse hepatocytes. Transient HBx
expression reduces global DNA repair in wild-type cells to
the level of p53-null hepatocytes and has no effect on the
repair of a transfected damaged plasmid [53]. Inhibition of
p53-mediated apoptosis by HBx may provide a clonal
selective advantage for hepatocytes expressing this inte-
grated viral gene during the early stages of human liver
carcinogenesis [54].
To date, a few mechanisms of HBV-induced HCC have
been proposed. Early studies proposed that insertional
mutagenesis of the HBV genome into human chromo-
somes might cause inactivation of tumor suppressor/
proto-oncogenes [80-82]. However, later studies have
shown that integration of HBV genome is genome-wide
and unlikely attacks a specific tumor suppressor or proto-
oncogene [82,83]. HBx initiates transactivation as well as
induction of signal transduction pathways such as Ras/
Raf-1 [84,85]. The large surface protein has been shown to
induce HCC in the transgenic mouse model [86,87]. Our
results are consistent to the hypothesis that HBx impedes
the DNA repair via interaction with TFIIH. In the dual
incision assay HBx120 or HBx121 mutants fail to impede
the repair process. These two residues seem to be critical
determinant in DNA repair in HBx mediated inhibition as
two mutants fail to interact with TFIIH.
Conclusions
In our study, we defined an inhibitory role of HBx in
DNA excision repair process, thus hampering the cellular
ability to repair the damaged DNA more effectively dur-
ing HBx expression. Recent studies on HCC in Taiwan,
the pre-S1/S2 mutant were shown to induce oxidative
stress and DNA damage in Ground glass hepatocytes
(GGHs), the pathological hallmarks for late phases of
chronic HBV infection [88]. Other studies have reported
that a defect in the ogg1 DNA repair gene is involved in
various types of human carcinogenesis [89]. Therefore,
efficient DNA repair for damaged DNA should play an
important role in cancer prevention. Our findings suggest
that HBx may act as the promoting factor by inhibiting
DNA repair causing DNA damage and accumulation of
errors, thereby contributing to HCC development.
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